Entrepreneurs of the pharmaceutical industry, medical associations, laboratories,
and business leaders, the Secretary of Economy, Ildefonso Guajardo Villarreal,
opened the International Forum "More and Better Health-Mexico 2030".
congratulated the Mexican Foundation for Health (FUNSALUD, by its initials in
Spanish) for the work that has served for three decades as one of the most
recognized research centers in Mexico and worldwide; evidence of this is the
recognition that the University of Pennsylvania extended them, who's ranked
them as the twelfth "think tank" most important in the health sector,
globally, during 2014.
Guajardo affirmed that the country needs a healthy workforce, to generate
productivity in order to have a more competitive country. He also noted that
the health sector is also attractive as a source of business, and that Mexico
"is now the first offering country of inputs of medical devices to the
United States and the tenth exporter worldwide, which creates jobs; if we
analyze how many Mexicans are working in the sector together with the
pharmaceutical industry, we found that there is more than 170,000 Mexicans
directly", he said.
He also noted that
"within this strategy of analysis and definition of a public policy in
conjunction with sectors of the health sector, we also arrived at the
fundamental point that has to do with protecting the innovation and encouraging
the opportunities that the Trans-Pacific Partnership Agreement (TPP) will bring
to the health sector, the Secretary Guajardo said that during the TPP
negotiations, Mexico promoted the right conditions to attract foreign
investment in innovative medicines, while it was guaranteed that the general
public has a timely access to generic medicines.
"More and Better Health-Mexico 2030" is coordinated by the COPARMEX
The aim of the
event is to create a shared vision of the health system that must be built for
Mexico in 2030. The Forum is aimed at officials and managers of public
institutions at the federal, state and municipal levels, as well as companies
and associations of the civil society related to attention, funding,
regulation, education and procurements of the health sector.